The Role of B Cells in Transplantation and Immunopathic Diseases

참고문헌 (37)

1. Basten A, "Tolerance and Autoimmunity: B cells. in: Autoimmune Diseases. 4th ed.", pp.167~177 (2006), Academic Press
2. Goodnow CC, "Multistep pathogenesis of autoimmune disease", Cell, 130, pp.25~35 (2007)
3. von Boehmer H, "Checkpoints in lymphocyte development and autoimmune disease", Nat Immunol, 11, pp.14~20 (2010)
4. Wardemann H, "B-cell self-tolerance in humans", Adv Immunol, 95, pp.83~110 (2007)
5. Phan TG, "The microanatomy of B cell activation", Curr Opin Immunol, 21, pp.258~265 (2009)
6. Cox SL, "Emerging roles for B lymphocytes in Type 1 diabetes", Expert Rev Clin Immu, 5, pp.311~324 (2009)
7. Singh A, "Regulatory role of B cells in a murine model of allergic airway disease", J Immunol, 180, pp.7318~7326 (2008)
8. Yanaba K, "B-lymphocyte contributions to human autoimmune disease", Immunol Rev, 223, pp.284~299 (2008)
9. DiLillo DJ, "B10 cells and regulatory B cells balance immune responses during inflammation, autoimmunity, and cancer", Ann N Y Acad Sci, 1183, pp.38~57 (2010)
10. Blair PA, "CD19(+)CD24(hi)CD38(hi) B cells exhibit regulatory capacity in healthy individuals but are functionally impaired in systemic Lupus Erythematosus patients", Immunity, 32, pp.129~140 (2010)
11. Skupsky J, "B-cell-delivered gene therapy induces functional T regulatory cells and leads to a loss of antigen-specific effector cells" (2010), Mol Ther
12. Silveira PA, "B cell selection defects underlie the development of diabetogenic APCs in nonobese diabetic mice", J Immunol, 172, pp.5086~5094 (2004)
13. Gavanescu I, "B cells are required for Aire-deficient mice to develop multi-organ autoinflammation:a therapeutic approach for APECED patients", Pro Natl Acad Sci U S A, 105, pp.13009~13014 (2008)
14. Browning JL, "B cells move to centre stage: novel opportunities for autoimmune disease treatment", Nat Rev Drug Discov, 5, pp.564~576 (2006)
15. Edwards JC, "Efficacy of B-cell-targeted therapy with rituximab in patients with rheumatoid arthritis", N Engl J Med, 350, pp.2572~2581 (2004)
16. Jacobi AM, "Current aspects of anti-CD20 therapy in rheumatoid arthritis" (2010), Curr Opin Pharmacol
17. Lee YH, "The efficacy and safety of rituximab for the treatment of active rheumatoid arthritis: a systematic review and meta-analysis of randomized controlled trials" (2010), Rheumatol Int
18. Merrill JT, "Efficacy and safety of rituximab in moderately-to-severely active systemic lupus erythematosus: the randomized, double-blind, phase II", III systemic lupus erythematosus evaluation of rituximab trial, 2010, pp.62, 222~233
19. Hauser SL, "B-cell depletion with rituximab in relapsing-remitting multiple sclerosis", N Engl J Med, 358, pp.676~688 (2008)
20. Bingham CO, "Immunization responses in rheumatoid arthritis patients treated with rituximab: results from a controlled clinical trial", Arthritis Rheum, 62, pp.64~74 (2010)
21. Kessel A, "Rituximab: beyond simple B cell depletion", Clin Rev Allergy Immunol, 34, pp.74~79 (2008)
22. Marino E, "CD4(+)CD25(+) T-cells control autoimmunity in the absence of B-cells", Diabetes, 58, pp.1568~1577 (2009)
23. Pescovitz MD, "Rituximab, B-lymphocyte depletion, and preservation of beta-cell function", N Eng J Med, 361, pp.2143~2152 (2009)
24. Thaunat O, "Am"B"valent: anti-CD20 antibodies unravel the dual role of B cells in immunopathogenesis", Blood (2010)
25. Ratanatharathorn V, "Clinical applications of rituximab in allogeneic stem cell transplantation: anti-tumor and immunomodulatory effects", Cancer Treat Rev, 35, pp.653~661 (2009)
26. "Guidelines for clinical usage of intravenous immunoglobulin civig in Australia", pp.160~165 (2008), National Blood Authority
27. Parsons RF, "B-cell tolerance in transplantation: is repertoire remodeling the answer?", Expert Rev Clin Immunol, 5, pp.703~ (2009)
28. Fan X, "Donor-specific B-cell tolerance after ABO-incompatible infant heart transplantation", Nat Med, 10, pp.1227~1233 (2004)
29. Gibbons C, "Manipulating the immune system for anti-tumor responses and transplant tolerance via mixed hematopoietic chimerism", Immunol Rev, 223, pp.334~360 (2008)
30. Zarkhin V, "Characterization of intra-graft B cells during renal allograft rejection", Kidney Int, 74, pp.664~673 (2008)
31. Zarkhin V, "A randomized, prospective trial of rituximab for acute rejection in pediatric renal transplantation", Am J Transplant, 8, pp.2607~2617 (2008)
32. Liu C, "B lymphocyte-directed immunotherapy promotes long-term islet allograft survival in nonhuman primates", Nat Med, 13, pp.1295~1298 (2007)
33. Terasaki PI, "Four-year follow-up of a prospective trial of HLA and MICA antibodies on kidney graft survival", Am J Transplant, 7, pp.408~415 (2007)
34. Turka LA, "Towards the identification of biomarkers of transplantation tolerance", Nat Rev Immunol, 9, pp.521~526 (2009)
35. Barnett JC, "Ovarian cancer tumor infiltrating T-regulatory (T(reg)) cells are associated with a metastatic phenotype", Gynecol Oncol, 116, pp.556~562 (2010)
36. Xu L, "Enrichment of CCR6+Foxp3+regulatory T cells in the tumor mass correlates with impaired CD8+ T cell function and poor prognosis of breast cancer", Clin Immunol, 135, pp.466~475 (2010)
37. Zhang HH, "Regulatory T cell depletion enhances tumor specific CD8 T-cell responses, elicited by tumor antigen NY-ESO-1b in hepatocellular carcinoma patients, in vitro", Int J Oncol, 36, pp.841~848 (2010)

관련 논문AI추천